Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Precision Telemed vs Luvo Health

Two GLP-1 deals, scored on the same six factors. Precision Telemed lands a Value Score of 89, Luvo Health a 66. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Precision Telemed

#10 · Grade A · Great Deal

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full Precision Telemed review →
VS

Luvo Health

#307 · Grade C · Watch List

Est. first month

From $249/mo (compounded)

Save ~82% vs brand-name
Get this deal Full Luvo Health review →

The verdict

Better value: Precision Telemed

Precision Telemed takes it on Value Score, 89 to 66 an est. $149/mo first month, with no teaser step-up baked in. Luvo Health isn't out of it: Shoppers who want compounded and brand GLP-1s, oral tablets and peptides from one published price list.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealPrecision TelemedLuvo Health
Value Score89 (A)66 (C)
Est. first month$149/moFrom $249/mo (compounded)
Save vs brand-name~89%~82%
Semaglutide$149/moFrom $249/mo (compounded)
Tirzepatide$199/moFrom $339/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
62
Precision Telemed: 88. Luvo Health: 62.
86
No Teaser-Rate Bait
62
Precision Telemed: 86. Luvo Health: 62.
98
Nationwide Availability
45
Precision Telemed: 98. Luvo Health: 45.
92
Both Molecules
98
Precision Telemed: 92. Luvo Health: 98.
84
Easy Cancellation
72
Precision Telemed: 84. Luvo Health: 72.
82
Reputation
65
Precision Telemed: 82. Luvo Health: 65.

Precision Telemed

A LegitScript-certified, all-50-state program with an honest $149 / $199 flat price on both molecules.

Why it's a deal

  • LegitScript-certified and available in all 50 states
  • Flat $149 semaglutide / $199 tirzepatide — no step-up
  • Both molecules priced up front

The fine print

  • Not the rock-bottom sticker — sub-$100 sema tiers exist
  • No brand-name or oral option

Luvo Health

Multi-program telehealth brand from LUVO HEALTH, INC.

Why it's a deal

  • Full price list published openly, by medication and by commitment length, with no intake required
  • Offers both compounded and brand-name Ozempic and Zepbound in one place
  • Oral semaglutide tablets available as well as injections
  • Full refund if a provider disqualifies you before medication is ordered
  • LegitScript certification verified against the issued seal, not just the badge

The fine print

  • Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
  • You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
  • Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
  • Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
  • Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back
Get the Precision Telemed deal Get the Luvo Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Precision Telemed is ranked on the Precision Telemed alternatives board, and the same list for the other side is on alternatives to Luvo Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.